Polysaccharide extract of Mimosa tenuiflora stem barks stimulates acute inflammatory response via nitric oxide

Extrato polissacarídico oriundo das cascas do caule de Mimosa tenuiflora induz resposta inflamatória aguda via óxido nítrico

Mimosa tenuiflora (Wild.) Poiret (Mimosaceae) is a plant commonly found in the northeast Brazil, where is popularly known as “jurema-preta” (Oliveira, Chiavone-Filho, Rodrigues & Medeiros, 1999). The bark powder is used in folk medicine to

treat skin burns, wounds and inflammation (Grether, 1988; Camargo-Ricalde, Grether, & Martínez-Bernal, 1994). In vivo experiments demonstrated the healing effect in human venous ulceration of the alcoholic extracts from M. tenuiflora cortex (Rivera-Arce et al., 2006) and the antinociceptive and anti-inflammatory activities of its barks (Cruz et al., 2016). In vitro, arabinogalactans (5 to 140 kDa) isolated from M. tenuiflora stimulates fibroblast and keratinocyte proliferation (Zippel, Deters, & Hensel, 2009). Besides, polysaccharides derived from higher plants are recognized for their relative nontoxicity, being ideal candidates for immunomodulatory, anti-tumor and wound-healing therapies (Meng et al., 2014; Pereira et al., 2012a; Zhou, Shi, Jiang, Zhou, & Xu, 2014; Lazareva et al., 2002). The aim of this study was to evaluate the inflammatory response of the polysaccharides extracted from M. tenuiflora stem barks in models of acute inflammation in rats.

The brown colored polysaccharide extract of M. tenuiflora stem barks (EP-Mt) yielded 3.8%, higher than those obtained from Caesalpinia ferrea pods (2.8%) (Pereira et al., 2012a) and Azadirachta indica teguments (1.3%), extracted by similar procedures (Pereira, Silva, Silva, Assreuy, & Pereira, 2012b). Yield variations of polysaccharide extraction can be explained by the changes in their distribution in plant parts and also by the type of extraction employed (Gottlieb & Borin, 2004). EP-Mt revealed high content of carbohydrate (41%), which was superior in comparison with that obtained from C. ferrea (31%) (Pereira et al., 2012a) and Erigeron canadensis flowers (34.1%) (Pawlaczyk et al., 2011). Importantly, the protein content (0.34%) was much less compared to the polysaccharides of Geoffroea spinosa barks (9%) (Silva et al., 2015), C. ferrea (3%) (Pereira et al., 2012a) and A. indica (4%) (Pereira et al., 2012b), both extracted by the same protocol. The low content of protein and high content of carbohydrate are justified by the conditions of polysaccharide extraction: high temperature, depigmentation by methanol, alkaline extraction and precipitation with ethanol (Yoon et al., 2002, Pereira et al., 2012a).

Although in the present study the analysis of phenolic compounds had not been assessed, in other study performed with M. tenuiflora barks, the presence of these compounds (minor residual amounts) was observed in the total polysaccharide extract. It is important to note that the authors could correlate the presence of phenolic compounds with the toxicity observed in cultured skin fibroblasts. Such effect was abolished after removal of the phenolic compound, which was associated to the polysaccharide (Zippel et al., 2009). In addition, previous phytochemical studies demonstrated presence of phenolic compounds (Jiag et al., 1991; Rivera-Arce et al., 2007), saponin, alkaloids, glucose, xylose, rhamnose, arabinose, lupeol, phytosterols, lipids, calcium oxalate crystals and starch (Jiag et al., 1991) in M. tenuiflora barks.

EP-Mt evoked paw edema in rats at all doses tested (0.01, 0.1 and 1 mg kg-1), showing a time course that was initiated at 30 min being maximal at 180 min. At 0.01 and 0.1 mg kg-1 the edema lasted up to 240 min and at 1 mg kg-1 up to 420 min (Figure 1A). The area under the edema time-course curve (AUC) showed that EP-Mt increased paw volume in 10 fold at 0.01 mg kg-1 (AUC: 26.9 ± 3.5) and 0.1 mg kg-1 (25.3 ± 0.7), while at 1 mg kg-1 the paw edema increase was about 40 fold (AUC: 102.5 ± 9.3) compared to saline (AUC: 2.5 ± 0.9 arbitrary units) (Figure 1B). The edematogenic effect of EP-Mt (1 mg kg-1) was inhibited mainly by L-NAME (52%) and by dexamethasone (26%) (Figure 1C).

In the peritonitis model, EP-Mt (1.0 mg kg-1, i.p.) increased the number of total leukocytes in 2.2 fold (6.980 ± 0.707 vs. saline: 3.140 ± 0.531 x 103 mL-1), mainly neutrophils in 6.5 fold (4.648 ± 0.467 vs. saline: 0.705 ± 0.158 x 103 mL-1) (Figure 2A). EP-Mt also increased MPO activity by 96% (14.3 ± 3.1 vs. saline: 4.9 ± 0.8 UMPO mL-1) (Figure 2B), an enzyme highly expressed in neutrophils that has been associated with the nitric oxide (NO) bioavailability (Galijašević, 2013). Accordingly, the pre-treatment with L-NAME (nitric oxide synthase inhibitor) reduced EP-Mt leukocyte migration by 38% (5.683 ± 0.481 x 103 mL-1). In addition, the treatment of animals with dexamethasone (a non-specific anti-inflammatory glucocorticoid) 180 min after EP-Mt administration, significantly reduced leukocyte migration by 39% (5.584 ± 0.193 x 103 mL-1). On the other hand, indomethacin (cyclooxygenase inhibitor) did not alter the leukocyte migration elicited by EP-Mt (Figure 2C).

The vascular permeability evaluated by Evans blue leakage at 30 min in the paw edema model was not altered, indicating that EP-Mt edematogenic effect is not of osmotic nature, different from that elicited by the polysaccharide dextran (Lo, Almeida, & Beaven, 1982). This data was confirmed by the lack of alteration in vascular permeability, seen by the protein dosage by the Bradford method evaluated at 180 min after peritonitis induction (Table 1).

Figure 1
EP-Mt edematogenic effect is inhibited by L-NAME and dexamethasone. EP-Mt (0.01, 0.1, 1 mg kg-1) was injected s.c. and the paw edema evaluated at zero time and from 30-420 min thereafter. (A) Edema time course (mL); (B) area under curve (AUC); (C) AUC of EP-Mt (1 mg kg-1) or EP-Mt + dexamethasone (5 mg kg-1; i.v.): evaluation from 30-240 min or; (D) EP-Mt + L-NAME (25 mg kg-1; i.v.): evaluation from 30-120 min. Mean ± S.E.M. (n = 6). One-way ANOVA and Bonferroni test. *p<0.05 vs. saline; #p<0.05 vs. 1 mg kg-1 EP-Mt

Table 1.
EP-Mt does not alter vascular permeability

a Evans Blue leakage (μg Evans blue/g paw); bBradford method (mg mL-1)

In acute inflammatory processes, macrophages, mast cells and lymphocytes have a modulator role in neutrophil migration releasing chemotactic factors, such as leukotrienes (LTB4) and cytokines: tumor necrosis factor-alpha (TNF-α) and interleukin 1 (IL-1) (Ranki, Sylvester, Smith, Yoshimura, & Leonard, 1990). The inhibitory effect of dexamethasone on EP-Mt chemotactic effect could be explained by the blockage of leukotrienes and/or cytokines release. Besides, the anti-inflammatory mechanism of dexamethasone includes the inhibition of the expression of various inflammatory genes, such as that of the inducible nitric oxide synthase (iNOS), leading to decreased production of NO (Korhonen, Lahti, Hämäläinen, Kankaanranta, & Moilanen, 2002; Secco et al., 2006; Moncada, Palmer, & Higgs, 1991). This data reinforces the inhibitory effect of L-NAME on the neutrophil migration stimulated by EP-Mt. Prostaglandins are mediators that also play a complex role in primary aspects of acute inflammatory response, such as pain, neutrophil migration, swelling and plasma exudation (Menezes et al., 2008). Our data demonstrated that the pre-treatment of animals with indomethacin did not alter the leukocyte migration, suggesting that prostaglandins are not crucial for the occurrence of leukocyte migration elicited by EP-Mt. In addition, it is possible to suggest that EP-Mt stimulates neutrophil chemotaxis, rather than vascular permeability. Furthermore, although not detected at the time-points evaluated in the peritonitis model, the possible EP-Mt effect in permeability could occur prior to its neutrophil chemotactic effect, which partially explains the inhibitory effect of L-NAME.

The effect of polysaccharides of higher plants in leukocytes, via macrophage activation, is extensively described in literature (Park et al., 2001; Sugawara, Lee, & Wong, 1984; Schepetkin, Faulkner, Nelson-Overton, Wiley, & Quinn, 2005; Schepetkin & Quinn, 2006). It has been shown that these compounds might stimulate macrophage phagocytic and cytotoxic activities against tumoral cells and micro-organisms, production of reactive oxygen species (ROS), and secretion of cytokines and chemokines. The polysaccharide of Juniperus scopolorum showed potent immunostimulant effect, via increase of NO production and release of proinflammatory cytokines by macrophages (IL-1, IL-6, TNF-α) (Schepetkin et al, 2005). In addition, the polysaccharide obtained from Dendobrium officinal raised macrophage levels of TNF-α, IL-1β (He et al., 2016) and NO production (Xia et al., 2012). Based on these, we believe that EP-Mt might stimulate leukocytes to release chemotactic substances, being considered a promisor candidate to be used in immunostimulant therapies.

Figure 2
EP-Mt elicits leukocyte migration. Peritonitis was induced by EP-Mt (1 mg kg-1; i.p.) in animals (A) naive or treated 30 min before with (B) dexamethasone (Dexa, 5 mg kg-1; i.v.), L-NAME (25 mg kg-1; i.v.) or indomethacin (Indo, 10 mg kg-1; i.v). Total and differential leukocyte counts or (C) MPO activity was evaluated 180 min after peritonitis induction; Mean ± E.P.M. (n=6). Two-way ANOVA and Bonferroni. *p < 0.05 vs. saline; #p < 0.05 vs. EP-Mt

The results reported in the present study clearly demonstrate that the polysaccharides extracted from M. tenuiflora stem barks, possessing high content of carbohydrate, elicit acute inflammation with the involvement of nitric oxide. It is worth mentioning the necessity to investigate molecules from natural sources presenting immunomodulatory effect, aiming the development of novel therapeutic agents for being used in pathological conditions of the immune system.

This research was supported by CAPES, CNPq and FUNCAP. Ana Maria S. Assreuy is a senior investigator of CNPq.